Clinical Trial Update: A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

View source ↗

Summary

Clinical trial update announcing the completion of a study evaluating palbociclib in breast cancer patients after its market introduction in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Status: COMPLETED